As psychedelic therapies advance through clinical development, pharmacists should prepare for potential roles in their safe, evidence-based integration into patient care.
Andrew Krut, PharmD, RPh
Advertisement
Articles by Andrew Krut, PharmD, RPh
Engagement and recognition of pharmacist expertise grows as state psychedelic bills expand.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves Bepirovirsen, First ASO for Chronic Hepatitis B
2
Operationalizing Therapy and Managing Hypophosphatemia Risk at UPMC
3
FDA Grants Accelerated Approval to Ravulizumab for Proteinuria Reduction in IgA Nephropathy
4
What Pharmacists Should Know About Sea Buckthorn for Respiratory Health
5